Company Search:
Advanced Search
Sponsored Links
PYC Therapeutics Ltd Company Snapshot
PYC Therapeutics Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares PYC Therapeutics Ltd with three other companies in this sector in AUSTRALIA : Kazia Therapeutics Ltd (2020 sales of 65,905.00 Australian Dollars [US$50,891.84 ] of which 100% was Pharmacetical research and development b), Cynata Therapeutics Ltd (65,951.00 Australian Dollars [US$50,927.36 ] ), and Vectus Biosystems Ltd (51,186.00 Australian Dollars [US$39,525.83 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
PYC Therapeutics Ltd
  Stock Performance Chart for PYC Therapeutics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/9/2021): .17
(Figures in Australian Dollars)
1 Week 6.3%   13 Weeks 17.2%  
4 Weeks 17.2%   52 Weeks 122.4%  
PYC Therapeutics Ltd Key Data:
  Ticker: PYC Country: Australia
  Exchanges: BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 62,500
(Year Ending Jan 2021).
Employees: 24
  Currency: Australian Dollars Market Cap: 539,057,438
  Fiscal Yr Ends: June Shares Outstanding: 3,170,926,103
  Share Type: Ordinary Closely Held Shares: 2,011,355,655
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.